United-Guardian Inc (UG)
NASDAQConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
$7.14+0.99%
Close 2026-09-04 · 1-day change
NASDAQConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
QuarterlyIQ Insights · UG
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -38.1% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 10.0% |
Growth built into the price is above our model estimate.
The price assumes 48.1 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of — · Company calendar date is not available
Why it matters: Keeping the dividend shows financial health. It shows commitment to shareholders.
Supportive ifThe company pays a dividend of $0.30 per share on August 4, 2026.
Worry ifThe company cuts the dividend below $0.30 per share.
Why it matters: ASI is a major distributor. Changes in their purchasing can signal shifts in demand for United-Guardian's products.
Watch forASI's purchases are up by more than 30% from last quarter.
Also watch forASI's purchases are down or the same as last quarter.
Why it matters: Keeping the dividend shows that the company cares about its shareholders. It also shows that management believes in the cash flow.
Supportive ifDividend per share remains at $0.25 or increases in Q2.
Worry ifDividend per share decreases further from $0.25 in Q2.
Why it matters: Strong growth in pharmaceutical sales is key to overall revenue growth. It signals ongoing demand for Renacidin.
Supportive ifQ2 pharmaceutical sales growth exceeds 20% year over year.
Worry ifPharmaceutical sales growth falls below 10% year over year.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$92 on $10,000 · ±0.9% | How much price usually moves either way. |
| Bad day | $348 loss on $10,000 · 3.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,396 loss on $10,000 · 34.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: The earnings report will provide key updates on revenue and profit trends. It will help assess management's growth strategy.
Watch forEarnings report shows revenue growth and profit margins improving.
Also watch forThe earnings report shows that revenue is down. Profit margins are also getting worse.
Why it matters: Sales are growing. This means people still want pharmaceuticals and cosmetic ingredients.
Supportive ifQ2 sales growth exceeds 20% year over year.
Worry ifQ2 sales growth falls below 10% year over year.
Why it matters: The dividend shows how well the company is doing. It also shows care for shareholders. A steady dividend can bring in investors.
Supportive ifThe cash dividend of $0.30 per share is paid as scheduled on August 4, 2026.
Worry ifThe dividend payment is delayed or canceled.
Why it matters: Strong growth in cosmetic ingredient sales shows high demand. This helps overall revenue growth.
Supportive ifCosmetic ingredient sales increase by more than 40% year over year in Q3.
Worry ifCosmetic ingredient sales growth falls below 30% year over year in Q3.
Why it matters: Renacidin is an important product. Strong sales show good demand and support overall earnings.
Supportive ifRenacidin sales increase by more than 10% year over year in Q3.
Worry ifRenacidin sales grow less than 5% year over year in Q3.
Why it matters: A steady or higher dividend shows financial health. It also shows management's confidence.
Supportive ifThe Board announces a dividend increase or maintains the current $0.30 per share.
Worry ifThe Board cuts the dividend below $0.30 per share.
Why it matters: Slower revenue growth may show problems. This can happen in a maturing sector.
Worry ifQ3 revenue growth prints above 10% year over year.
Less concerning ifQ3 revenue growth falls below 5% year over year.